Armata Pharmaceuticals Inc
Research Armata Pharmaceuticals Inc (ARMP) on Bullrun: market cap USD 134.84M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerARMP
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 134.84M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 115.35M
- Free cash flow-USD 5.85M
Valuation Snapshot
latest market cap is USD 134.84M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 173.80M | -USD 26.31M | n/a | -4.8 | USD 8.69M | USD 288.02M | -USD 218.60M |
| FY2024 | USD 0 | -USD 18.92M | -USD 39.43M | n/a | -0.89 | USD 9.29M | USD 126.52M | -USD 48.02M |
| FY2023 | USD 0 | -USD 69.05M | -USD 55.57M | n/a | -1.91 | USD 13.52M | USD 120.37M | -USD 32.07M |
| FY2022 | USD 0 | -USD 36.92M | -USD 34.69M | n/a | -1.08 | USD 14.85M | USD 48.82M | USD 36.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 134.84M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 228.79M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 66.94M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 117.11M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 44.82M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 148.58M | n/a | n/a | n/a |
About Armata Pharmaceuticals Inc
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Armata Pharmaceuticals Inc's market cap?
Armata Pharmaceuticals Inc's market capitalization is USD 134.84M.
What does Armata Pharmaceuticals Inc do?
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.